You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Sept. 16, 2014 /PRNewswire/ -- Astellas announced today it has appointed Christy Noland as a new director of Business Communications & Advocacy, Urology in the Americas. Noland will report directly to Vice President, Business Communications & Advocacy Margaret Long. In this role, Noland will be responsible for communicating Astellas' commitment to urology to patient and advocacy organizations, as well as collaborating with the urology brand teams on key strategic initiatives. Noland's appointment is the latest phase in the building of a new Corporate Communications team under the leadership of Jeff Winton, senior vice president, chief communications officer.
"Christy has an outstanding reputation in the business and we're thrilled to bring her onto our growing team," said Long. "Her experience working in both the pharmaceutical industry and the patient advocacy community has provided Christy valuable insights that will help drive the goals of the urology team and the patients we serve."
Noland comes to Astellas from Baxter International Inc., where she was a director of communications for the renal business. Prior to that, Noland worked at several leading public relations agencies, including GolinHarris, Burson-Marsteller and Edelman, where her clients ranged from large pharmaceutical companies to patient and physician advocacy groups. In addition, she worked with the Depression and Bipolar Support Alliance in advocating for medical records privacy and mental health insurance parity. She earned her B.S. in advertising at the University of Illinois at Urbana-Champaign.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.